NovaQuest Pharma Opportunities Fund VI, L.P. — Form D/A
NovaQuest Pharma Opportunities Fund VI, L.P. of RALEIGH, NC, a pooled investment fund, filed a Form D amendment with the SEC on 2023-04-27. The offering totals $800.0M. Industry: Pooled Investment Fund.
Offering
- Filed: 2023-04-27
- Form: D/A
- Accession: 0001012975-23-000203
- Industry: Pooled Investment Fund
- Exemptions: 06b, 3C, 3C.7
- Total offering: $800.0M
- Remaining: $800.0M
- Security types: fund interests
- Revenue range: Not Applicable
- SEC file number: 021-479248
Issuer
- Name: NovaQuest Pharma Opportunities Fund VI, L.P.
- CIK: 0001944276
- Entity type: Limited Partnership
- Jurisdiction: CAYMAN ISLANDS
- Incorporated: 2022
- Address: 4208 SIX FORKS ROAD, RALEIGH, NC, 27609
- Phone: 919-459-8620
Officers, directors & promoters (9)
| Name | Role | Location |
|---|
| RYAN APPLEGATE | Director | DURHAM, NC |
| Carl Gerald Hellman | Director | Raleigh, NC |
| Michael Gerald Bologna | Director | Raleigh, NC |
| Patrick E Jordan | Director | Raleigh, NC |
| Hidekazu E Tanaka | Director | Raleigh, NC |
| Jonathan E Tunnicliffe | Director | Raleigh, NC |
| N/A NQ POF VI GP, Ltd. | Executive Officer | Raleigh, NC |
| Ernest Gerald Brown | Director | Raleigh, NC |
| N/A NQ POF VI GP, L.P. | Executive Officer | Raleigh, NC |
Other filings by this issuer (3)
More